Showing results (151-160 of 417) with videos related to
Sort By:
Pageof 42
Anticancer Research|July 27, 2023
Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 InhibitorAndrew Hunt, Waqar Haque, Ramiro Pino, et al.Differentiation; Research in Biological Diversity|August 16, 2003
HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiationStephanie A Miller, Anissa J Brown, Mary C Farach-Carson, et al.American Journal of Medical Genetics. Part A|September 16, 2020
The first reported case of Loeys-Dietz syndrome in a patient with biallelic SMAD3 variantsStephanie M Baskin, Shaine A Morris, Autumn Vara, et al.Journal of Biomedical Materials Research. Part A|August 10, 2010
Fiber diameters control osteoblastic cell migration and differentiation in electrospun gelatinKristin Sisson, Chu Zhang, Mary C Farach-Carson, et al.Journal of Neurosurgery. Case Lessons|January 31, 2023
Leptomeningeal metastasis from neuroendocrine carcinoma of the cervix: illustrative caseJohn D Patterson, Andrew M Farach, Monisha Singh, et al.Biomaterials|January 23, 2014
A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeuticsXian Xu, Chandran R Sabanayagam, Daniel A Harrington, et al.Experimental Cell Research|December 29, 2009
Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cellsCynthia L Richard, Mary C Farach-Carson, Ben Rohe, et al.Biochemical and Biophysical Research Communications|June 30, 2000
1,25 dihydroxyvitamin D(3) activates sphingomyelin turnover in ROS17/2.8 osteosarcoma cells without sphingolipid-induced changes in cytosolic Ca(2+)R Liu, Y Xu, M C Farach-Carson, et al.Journal of Cellular Biochemistry|July 4, 2006
Mechanism of 24,25-dihydroxyvitamin D3-mediated inhibition of rapid, 1,25-dihydroxyvitamin D3-induced responses: role of reactive oxygen speciesIlka Nemere, Cody Wilson, Wendy Jensen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 23, 2018
Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancerWaqar Haque, Vivek Verma, Praveen Polamraju, et al.Pageof 42